youtube_live
Q3 2026 earnings • in 3 days
See detailschevron_right
ELAN:NYSE
Elanco Animal Health Inc
$24.10
arrow_upward
+4.51%(+1.04) 1D
$24.23
arrow_upward
+0.54% (+0.13)todayPre-market
Closed: Nov 2, 4:00:04 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ELAN...
Open
$23.55
High
$24.22
Low
$23.31
Mkt. cap
12.04B
Avg. vol.
5.03M
Volume
282.00
52-wk high
$27.98
52-wk low
$19.40
EPS
-$0.42
Beta
1.71
Shares outstanding
499.62M
No. of employees
10K
Open
$23.55
High
$24.22
Low
$23.31
Mkt. cap
12.04B
Avg. vol.
5.03M
Volume
282.00
52-wk high
$27.98
52-wk low
$19.40
EPS
-$0.42
Beta
1.71
Shares outstanding
499.62M
No. of employees
10K
News stories
From web sources and news partners
Zacks
·
19 hours ago
RadNet (RDNT) Reports Next Week: Wall Street Expects Earnings Growth
Profile
Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world. Wikipedia
About Elanco Animal Health Inc
CEOJeffrey N. Simmons
Employees9.65K
Founded1954
HeadquartersIndianapolis, Indiana, United States
SectorPharmaceutical industry
Websiteelanco.com